Device Trial Radar · NCT07216885
Solv Multi-Pass Hemodialysis System In-Center Clinical Study
Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
4
Actual
Start
Jan 13, 2026
Primary completion
Sep 11, 2026
Study completion Sep 11, 2026
Sponsor
- Lead sponsor
- Mozarc Medical US LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 15, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.
Conditions
- End Stage Renal Disease
Interventions
Solv Multi-Pass Hemodialysis SystemDevice
Solv Multi-Pass Hemodialysis System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: through study completion, an average of 1 year
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Carolina Nephrology
Greenville, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.